Aequus Pharmaceuticals Company Description

Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada.

The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension.

It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Aequus Pharmaceuticals Inc.

Country	Canada
Founded	2013
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	12
CEO	Douglas Janzen

Contact Details

Address: 200 Granville Street Vancouver, British Columbia V6C 1S4 Canada
Phone	604 336 7906
Website	aequuspharma.ca

Stock Details

Ticker Symbol	AQS
Exchange	TSX Venture Exchange
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA0076361033
SIC Code	2834

Key Executives

Name	Position
Douglas Glen Janzen	Chairman, Chief Executive Officer and President